source
- GLP-1 drugs and eating disorder risk examined as Covid impact wanes in 2026The Morning Rounds newsletter explores the potential link between GLP-1 medications and the development of eating disorders, emphasizing that the risk remains uncertain and warrants further study.…
- CDC-funded hepatitis B vaccine trial in Guinea-Bissau paused amid ethical concernsThe U.S. Centers for Disease Control and Prevention awarded a $1.6 million grant to a Danish research group to compare hepatitis B vaccination at birth versus at six weeks in infants from Guinea‑Bi…